BUPRENORPHINANALOGA

European patent · EP2326651 · Deleted

Register entry

Publication number
EP2326651
Application number
EP09789036
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 30, 2009
Published
Jun 1, 2011
Granted
Nov 27, 2013
Deleted
Jul 31, 2017
Reason
Annual fee unpaid
IPC classes
C07D 489/12 (2006.01)
A61K 31/485 (2006.01)
A61P 25/04 (2006.01)
Priority
US 226119 P 16.07.2009
US 84764 P 30.07.2008
PCT application
PCT/US2009/004391 30.07.2009
PCT publication
WO2010/014229 04.02.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 21, 2018

    Deleted, fee unpaid

    Published in Swissreg on 21.02.2018

  2. Sep 30, 2016

    Address changed

    Representative
    Maiwald Patentanwaltsgesellschaft (Schweiz) mbH, Splügenstrasse 8, 8002 Zürich → Gottschalk Maiwald Patentanwalts- und Rechtsanwalts- (Schweiz) GmbH, Splügenstrasse 8, 8002 Zürich

    Published in Swissreg on 30.09.2016

  3. Dec 3, 2013

    Agent entered

    Representative
    Maiwald Patentanwaltsgesellschaft (Schweiz) mbH, Splügenstrasse 8, 8002 Zürich

    Published in Swissreg on 03.12.2013

  4. Nov 27, 2013

    Granted

    Published in Swissreg on 27.11.2013

Parties

Holder

Purdue Pharma LP

One Stamford Forum 201 Tresser Boulevard, Stamford, CT 06901, US

Agent

Gottschalk Maiwald Patentanwalts- und Rechtsanwalts- (Schweiz) GmbH

Splügenstrasse 8, 8002 Zürich

Inventor

KYLE, Donald, J.

Newtown, PA 18940, US

GOEHRING, R., Richard

Dublin, PA 18917, US

FUNDYTUS, Marian, E.

Burlington, NJ 08016, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.